1. Home
  2. CGC vs PRQR Comparison

CGC vs PRQR Comparison

Compare CGC & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGC
  • PRQR
  • Stock Information
  • Founded
  • CGC N/A
  • PRQR 2012
  • Country
  • CGC Canada
  • PRQR Netherlands
  • Employees
  • CGC N/A
  • PRQR N/A
  • Industry
  • CGC Pharmaceuticals and Biotechnology
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CGC Health Care
  • PRQR Health Care
  • Exchange
  • CGC Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • CGC 239.2M
  • PRQR 244.4M
  • IPO Year
  • CGC N/A
  • PRQR 2014
  • Fundamental
  • Price
  • CGC $1.14
  • PRQR $2.23
  • Analyst Decision
  • CGC Hold
  • PRQR Strong Buy
  • Analyst Count
  • CGC 1
  • PRQR 8
  • Target Price
  • CGC N/A
  • PRQR $8.88
  • AVG Volume (30 Days)
  • CGC 10.1M
  • PRQR 281.4K
  • Earning Date
  • CGC 08-08-2025
  • PRQR 08-07-2025
  • Dividend Yield
  • CGC N/A
  • PRQR N/A
  • EPS Growth
  • CGC N/A
  • PRQR N/A
  • EPS
  • CGC N/A
  • PRQR N/A
  • Revenue
  • CGC $187,146,485.00
  • PRQR $21,212,711.00
  • Revenue This Year
  • CGC $11.99
  • PRQR N/A
  • Revenue Next Year
  • CGC $6.84
  • PRQR N/A
  • P/E Ratio
  • CGC N/A
  • PRQR N/A
  • Revenue Growth
  • CGC N/A
  • PRQR 85.91
  • 52 Week Low
  • CGC $0.77
  • PRQR $1.07
  • 52 Week High
  • CGC $8.04
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • CGC 45.22
  • PRQR 53.12
  • Support Level
  • CGC $1.08
  • PRQR $2.11
  • Resistance Level
  • CGC $1.27
  • PRQR $2.39
  • Average True Range (ATR)
  • CGC 0.08
  • PRQR 0.15
  • MACD
  • CGC 0.01
  • PRQR -0.03
  • Stochastic Oscillator
  • CGC 26.92
  • PRQR 30.73

About CGC Canopy Growth Corporation

Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: